RC48 for Neoadjuvant Chemotherapy of HER2 Positive Breast Cancer
Clinical trial NCT05134519 · UNKNOWN
Trial details
- NCT number
- NCT05134519
- Sponsor
- Xijing Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-26
- Primary completion
- 2024-09-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.